Findings!
For a trial-representative cohort of 100,000 individuals, compared to usual care, polypill treatment:
- prevented 2,738 CVD events
- yielded 1,190 QALYs
- increased costs by ~$10,152,000
Hence, polypill treatment cost $8,560-per-QALY gained and was high value.
